´
M. Mastihubova et al. / Bioorg. Med. Chem. 14 (2006) 1805–1810
1809
0
7 by column chromatography (toluene/ethyl acetate,
2:1) to give 3 as a white solid (0.32 g, 90%). Mp =
OH), 4.29 (dd, 1H, J4,5 4.7 and J5;5 12.3 Hz, H-5),
4.41 (dd, 1H, J4;5 3.1 and J5;5 12.5 Hz, H-50), 4.45 (m,
1H, H-4), 4.48 (br d, 1H, H-2), 4.80 (dd, 1H, J2,3 2.7
and J3,4 6.3 Hz, H-3), 5.76 (s, 1H, H-1), 7.12 (d, 2H, J
9.3 Hz, H-20, H-60), 8.21 (d, 2H, J 9.3 Hz, H-30, H-50).
13C NMR (75 MHz CDCl3) d d 20.7 (2 · COCH3),
62.7 (C-5), 80.5, 80.8, 81.2 (C-2, C-3, C-4), 105.8 (C-
1), 2 · 116.4, 2 · 125.8, 142.6, 161.1 (6 · C-Ar), 170.5
(COCH3), 171.8 (COCH3). Anal. Calcd for
C15H17NO9: C, 50.71; H, 4.82, N, 3.94. Found: C,
0
0
77–79 ꢁC
(isopropyl
alcohol/diisopropyl
ether);
20
½aꢁ ꢀ141.0 (c 1.0, CHCl3); [lit. 35 77–79 ꢁC (diisopropyl
D
20
1
ether); ½aꢁ ꢀ142 (c 1.2, CHCl3)]. H NMR (300 MHz,
CDCl3) dDd 1.63 (br s, 1H, OH), 2.15 (s, 3H, COCH3),
0
2.16 (s, 3H, COCH3), 3.84 (dd, 1H, J4,5 4.0 and J5;5
0
0
12.3 Hz, H-5), 3.92 (dd, 1H, J4;5 3.4 and J5;5 12.3 Hz,
H-50), 4.25 (dt, 1H, H-4), 5.20 (dd, 1H, J3,4 5.2 and
J2,3 1.8 Hz, H-3), 5.43 (d, J1,2 0 and J2,3 1.8 Hz, H-2),
5.9 (d, 1H, H-1), 7.15 (d, 2H, J 9.2 Hz, H-20, H-60),
50.71; H, 5.00; N, 3.98. Next eluted was oily 4 (0.33 g
20
25%). ½aꢁ ꢀ156.0 (c 1.0, CHCl3). 1H NMR
8.21 (d, 2H,
J
9.2 Hz, H-30, H-50). 13C NMR
D
(75 MHz, CDCl3) d d 20.8 (2 · COCH3), 61.7 (C-5),
76.6 (C-3), 81.6 (C-2), 84.6 (C-4), 103.7 (C-1),
2 · 116.6, 2 · 125.8, 142.8, 160.8 (6 · C-Ar), 169.7
(COCH3), 170.5 (COCH3). Anal. Calcd for
C15H17NO9: C, 50.71; H, 4.82; N, 3.94. Found: C,
50.42; H, 5.17; N, 3.69.
(300 MHz, CDCl3) d d 2.11 (s, 3H, COCH3), 2.18 (s,
3H, COCH3), 3.32 (br s, 1H, OH), 4.12 (dd, 1H, J2,3
0
3.4 and J3;4 6.4 Hz, H-3), 4.27 (dd, 1H, J4,5 6.3 and
0
J5;5 12.9 Hz, H-5), 4.36 (m, 1H, H-4), 4.38 (dd, 1H,
J4;5 3.2 and J5;5 13.0 Hz, H-50), 5.18 (dd, J1,2 1.1 and
J2,3 3.4 Hz, H-2), 5.81 (d, J1,2 1.1 Hz, H-1), 7.14 (d,
2H, J 9.3 Hz, H-20, H-60), 8.21 (d, 2H, J 9.3 Hz, H-30,
0
0
4.3. HPLC test for the acetyl migration
H-50). 13C NMR (75 MHz, CDCl3)
d
d
20.7
(2 · COCH3), 62.8 (C-5), 76.9 (C-3), 82.1 (C-4), 86.1
(C-2), 103.7 (C-1), 2 · 116.5, 2 · 125.7, 142.7, 160.9
(6 · C-Ar), 170.8 (COCH3), 171.4 (COCH3). Anal.
Calcd for C15H17NO9: C, 50.71; H, 4.82, N, 3.94.
Found: C, 50.57; H, 5.07; N, 3.53.
Di-O-acetate 3 (0.002 mmol) was dissolved in DMSO
(80 lL) and mixed with 0.1 M sodium phosphate buffer
(1920 lL) of pH 6 preheated to 40 ꢁC. The reaction mix-
tures were incubated at 40 ꢁC for several days. The ali-
quots (50 lL) were withdrawn at time intervals and
directly injected to the HPLC system through a 20 lL
loop using a silica gel column eluted with hexane/ethyl
acetate, 3:2, rate 1 mL/min. The graphical illustration
of the monitored process is shown in Figure 2.
4.6. p-Nitrophenyl 5-O-acetyl-a-L-arabinofuranoside (6)
p-Nitrophenyl a-L-arabinofuranoside 2 (0.27 g, 1 mmol)
was dissolved in THF (25 mL) and vinyl acetate
(1.4 mL, 15 mmol) followed by PPL (1 g) was added.
The reaction mixture was shaken at 40 ꢁC and
200 rpm for 15 h. The reaction was stopped by filtering
off the lipase. The filtrate was concentrated and the res-
idue was purified by column chromatography (toluene/
ethyl acetate, 1:2) to give only monoacetate 6 (0.30 g,
4.4. Monitoring of di-O-acetylation of p-nitrophenyl a-L-
arabinofuranoside
p-Nitrophenyl a-L-arabinofuranoside (2) (27.1 mg,
0.1 mmol) was dissolved in a selected organic solvent
20
D
1
˚
(954 lL) and then molecular sieve (4 A, 250 mg), vinyl
95%) as a colourless oil. ½aꢁ ꢀ133 (c 1.0, CHCl3). H
acetate (46 lL, 5 equiv) and 270 mg LPS were added.
The reaction mixtures were shaken at 40 ꢁC at
200 rpm. Aliquots were withdrawn in different time
intervals and filtered (Durapore filter, 0.45 lm). The fil-
tered solutions were analysed by HPLC on a silica gel
column in hexane/ethyl acetate, 1:1, at an elution rate
of 1.5 mL/min. The ratios of compounds, calculated
from the integrated peak areas, are shown in Table 1.
NMR (300 MHz, CDCl3) d d 2.12 (s, 3H, COCH3),
2.81 (br s, 2H, OH), 4.10 (dd, 1H, J2,3 3.8 and J3,4
5.1 Hz, H-3), 4.29–4.34 (m, 3H, H-4, H-5, H-50), 4.49
0
0
(dd, 1H, J1;2 1.6 and J2;3 3.7 Hz, H-2), 5.71 (d, J1,2
1.5 Hz, H-1), 7.12 (d, 2H, J 9.2 Hz, H-20, H-60), 8.18
(d, 2H, J 9.2 Hz, H-30, H-50). 13C NMR (75 MHz,
CDCl3) d d 20.8 (COCH3), 63.4 (C-5), 77.8 (C-3), 81.4
(C-2), 83.6 (C-4), 106.0 (C-1), 2 · 116.5, 2 · 125.8,
142.7, 161.7 (C-Ar), 170.8 (COCH3). Anal. Calcd for
C13H15NO8: C, 49.84; H, 4.83, N, 4.47. Found: C,
50.06; H, 5.01; N, 4.05.
4.5. p-Nitrophenyl 2,5- and 3,5-di-O-acetyl-a-L-arabino-
furanoside (4 and 5)
p-Nitrophenyl a-L-arabinofuranoside (2) (1 g, 3.7 mmol)
was suspended in diisopropyl ether (300 mL). Molecular
4.7. p-Nitrophenyl 2-O-acetyl-a-L-arabinofuranoside (7)
˚
sieves (4 A, 5 g), vinyl acetate (3.4 mL, 37 mmol,
2,5-Diacetate 4 (0.18 g, 0.5 mmol) was dissolved in
DMF (1.5 mL), then 0.1 M phosphate buffer, pH 6
(13.5 mL), was added followed by addition of CCL
(0.1 g). The reaction mixture was shaken at 37 ꢁC and
200 rpm for 7 h. Then ethyl acetate was added to the
reaction mixture and products were extracted from the
aqueous mixture. The organic phase was dried (Na2SO4)
and concentrated under reduced pressure. The 2-acetate
7 was separated from 2 and traces of the starting com-
pound and 6 by column chromatography (toluene/ethyl
acetate, 1:1) to give 7 as a colourless oil (0.11 g, 76%).
10 equiv) and lipase PS (9 g) were added. The reaction
mixture was shaken at 37 ꢁC and 200 rpm for 30 h.
The reaction was stopped by filtration off the lipase,
which was then repeatedly used in four subsequent reac-
tion cycles. The filtrate was concentrated and the residue
was fractionated by column chromatography (toluene/
ethyl acetate, 5:1 ! 2:1) to give first 1 as an oil (0.06 g,
7%), then 5 as a white solid (0.48 g, 61%). Mp = 67–
20
68 ꢁC (diisopropyl ether/cyclohexane). ½aꢁ ꢀ200.0 (c
D
1
1.0, CHCl3). H NMR (300 MHz, CDCl3) d d 2.12 (s,
3H, COCH3), 2.18 (s, 3H, COCH3), 3.21 (br s, 1H,
20
D
1
½aꢁ ꢀ160 (c 1.0, CHCl3). H NMR (300 MHz, CDCl3)